TransUnion (NYSE: TRU) has announced that it completed the sale of TransUnion Healthcare, Inc. (“TransUnion Healthcare”) to nThrive, Inc. (“nThrive”), a leading healthcare revenue cycle management (“RCM”) software-as-a-service (“SaaS”) platform backed by Clearlake Capital Group, L.P. (together with certain affiliates, “Clearlake”), for $1.735 billion in cash.
The transaction is expected to result in approximately $1.4 billion in after-tax proceeds at current tax rates.
TransUnion Healthcare provides nThrive with powerful healthcare data and analytics capabilities that enable simple, efficient and accurate end-to-end RCM outcomes for healthcare providers and payers.
“The complementary nature of nThrive’s and TransUnion Healthcare’s solutions, as well as Clearlake’s dedicated focus in healthcare technology, make this a compelling and exciting combination. We look forward to a productive ongoing relationship with nThrive,” said Chris Cartwright, President and CEO of TransUnion. “With this divestiture completed, TransUnion further tightens our focus on providing credit, marketing and fraud mitigation solutions to help businesses and consumers transact with greater certainty.”
Centerview Partners LLC acted as lead financial advisor to TransUnion. Latham & Watkins LLP served as legal advisor to TransUnion.
Source: TransUnion Press Release
